Doris Fuertinger, PhD, shares her research on how individualized #anemia therapy improves #hemoglobin outcomes and decreases epoetin beta drug exposure in #hemodialysis patients at the #ERA-EDTA 2023 Conference and in this edition of #ResearchSpotlight.
Read more about Dr. Fuertinger's research here: www.asn-online...
#renal #renalcare #RRI #CKD #kidneydisease #dialysis ##renalresearch #renalresearchinstitute
Негізгі бет Research Spotlight | Doris Fuertinger, PhD | Anemia & Hemoglobin | ERA-EDTA 2023
Пікірлер